Table 3.
Characteristic | Odds ratio (95% CI) | P value | |
---|---|---|---|
Bacterial pneumonia to COVID-19 |
WBC (×109/L) | ||
3.5–9.5 | Reference | ||
<3.5 | 5.531 (0.569–53.756) | 0.140 | |
>9.5 | 0.134 (0.026–0.699) | 0.017 | |
Monocytes (%) | |||
<10% | Reference | ||
>10% | 1.838 (0.966–3.498) | 0.064 | |
Eosinophils (%) | |||
>0.4% | Reference | ||
<0.4% | 6.654 (2.210–20.027) | 0.001 | |
SAA (mg/L) | |||
<10 | Reference | ||
>10 | 2.798 (0.826–9.479) | 0.098 | |
Influenza to COVID-19 |
Age (years) | 2.255 (0.856–5.941) | 0.100 |
WBC (×109/L) | |||
3.5–9.5 | Reference | ||
<3.5 | 0.172 (0.010–3.099) | 0.233 | |
>9.5 | 0.247 (0.008–7.260) | 0.418 | |
Neutrophil (%) | |||
<75% | Reference | ||
>75% | 0.691 (0.207–2.311) | 0.549 | |
Monocytes (%) | |||
<10% | Reference | ||
>10% | 0.147 (0.042–0.521) | 0.003 | |
NLR | |||
<3.72 | Reference | ||
>3.72 | 0.141 (0.024–0.811) | 0.028 | |
LMR | |||
<2.74 | 96.442 (8.332–1116.248) | <0.001 | |
>2.74 | Reference |
WBC = white blood cell; SAA = serum amyloid A; NLR = neutrophil-to-lymphocyte ratio; LMR = lymphocyte-to-monocyte ratio.